Home・Aandelen Lijst・Capricor Therapeutics Inc

Capricor Therapeutics Inc

Gesloten

6.09 6.65

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

5.68

Max

5.92

Belangrijke statistieken
By Trading Economics
Inkomsten	-6.8M -41M
EPS	-0.7
Werknemers	231
EBITDA	289M 255M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+355.31% upside

Dividenden
By Acuity
Volgende Winsten	9 nov 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	164M 387M
Vorige openingsprijs	-0.56
Vorige sluitingsprijs	6.09

Capricor Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

26 okt 2026, 23:56 UTC

Humana Inc. is trading higher in after-market hours, reflecting routine performance within a narrow range above its 20-day moving average.

26 okt 2026, 23:56 UTC

Ares Capital Corp is trading higher in after-market hours, maintaining a slight gain since Monday's close and near the lower end of its one-month range.

26 okt 2026, 23:56 UTC

Xcel Energy Inc is trading modestly lower in after-market hours, remaining above its 20-day moving average and near the upper end of its one-month trading range.

26 okt 2026, 23:56 UTC

United Therapeutics Corp shares advanced in after-market trading, recovering from an initial dip and maintaining a modest upward trajectory above its 20-day moving average.

26 okt 2026, 23:56 UTC

News

Principal Financial Group reports Q3 net income of $631.9 million, but adjusted EPS of $2.22 missed estimates, contributing to after-market declines.

26 okt 2026, 23:56 UTC

Savara Inc's shares advanced in after-market trading, reflecting a notable rise since Monday's close, though still below its 20-day moving average.

26 okt 2026, 23:56 UTC

News

Piper Sandler initiates coverage on HF Sinclair Corp with an Overweight rating, reflecting a positive outlook for the company.

26 okt 2026, 23:56 UTC

International Seaways Inc shares are trading modestly lower in after-market hours, having retraced from an earlier gain that briefly pushed the stock positive.

26 okt 2026, 23:56 UTC

Sunstone Hotel Investors Inc shares advanced modestly higher in after-market hours on Monday, trading above its 20-day moving average and near the upper end of its one-month range.

26 okt 2026, 23:56 UTC

Vulcan Materials Co shares traded lower in after-market hours, continuing a downward trend and reaching a low point below Monday's close.

26 okt 2026, 23:56 UTC

EUR/NOK is lower, continuing a four-session trend of weakness, currently near its daily low amid broader performance below the 20-day moving average.

26 okt 2026, 23:52 UTC

In after-market trading, Inspire Medical Systems Inc shares are advancing, reaching their highest point of the day and significantly above their 20-day moving average.

26 okt 2026, 23:52 UTC

America's CAR-MART Inc shares fell sharply in after-market trading, continuing a trend of lower daily closes over the past three sessions.

26 okt 2026, 23:52 UTC

Correlated Moves

Coeur Mining, Inc. shares traded lower in after-market hours on Monday, reversing from an early gain amid little change in correlated asset XAU/USD.

26 okt 2026, 23:52 UTC

Macro News

Gold prices are declining amid mixed economic signals, currently positioned around the lower end of its one-month range and below its 20-day moving average.

26 okt 2026, 23:52 UTC

South Korea's Q3 GDP growth surpasses expectations at 3.4%, boosting market sentiment despite concerns over private consumption decline.

26 okt 2026, 23:52 UTC

South Korea's Q3 2026 GDP Growth Surges to 1.0%, Exceeding Expectations and Boosting Economic Optimism Despite Declining Consumer Spending

26 okt 2026, 23:52 UTC

Germany's October inflation rate expected to rise to 3% amid easing oil prices and positive economic indicators, fueling cautious optimism in financial markets.

26 okt 2026, 23:52 UTC

U.S. Initial Jobless Claims Expected at 200,000 Amid Positive Labor Market Sentiment and Economic Uncertainties on October 29, 2026

26 okt 2026, 23:52 UTC

Euro Area's Deposit Facility Rate Release on October 29 Expected to Hold at 0.025% Amid Cautious Optimism and Inflation Concerns

26 okt 2026, 23:52 UTC

Upcoming New Home Sales Data Release on October 27, 2026, Forecasts 0.65 Million Units Amid Shifting Housing Market Sentiment and Federal Reserve Policy Impacts.

26 okt 2026, 23:52 UTC

Cautious Expectations for October New Home Sales Amid Rising Mortgage Rates and Slowing Price Growth

26 okt 2026, 23:52 UTC

Germany's October Inflation Rate Expected to Hold at 0.0%, Amid Optimism from Falling Oil Prices and Rising Business Confidence

26 okt 2026, 23:52 UTC

Paychex Inc shares are trading lower in after-market hours, maintaining a cumulative return decline while remaining above the 20-day moving average.

26 okt 2026, 23:51 UTC

The USD/HUF is trading modestly higher, continuing an upward trend, supported by improved economic indicators, including a rise in the Chicago Fed National Activity Index.

26 okt 2026, 23:51 UTC

Social Media

News

Robinhood shares are modestly higher in after-market trading following Bernstein's forecast of $1.7 billion in annual revenue from prediction markets by 2028.

26 okt 2026, 23:51 UTC

CVS Health Corp shares are trading modestly higher in after-market hours, remaining above its 20-day moving average and near the upper end of its one-month range.

26 okt 2026, 23:51 UTC

Cerence Inc is experiencing a significant decline in after-market trading, falling sharply from its earlier peak and positioned below its 20-day moving average.

26 okt 2026, 23:51 UTC

Roku Inc is trading modestly higher in after-market hours, reaching its highest level since Monday's close and positioning well above its 20-day moving average.

26 okt 2026, 23:51 UTC

IPG Photonics Corp has risen in after-market trading, recovering from an initial dip to reach its highest cumulative return since Monday's close.

Peer Vergelijking

Prijswijziging

Capricor Therapeutics Inc Prognose

Koersdoel

By TipRanks

355.31% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 27 USD 355.31%

Hoogste 54 USD

Laagste 7 USD

Gebaseerd op 10 Wall Street-analisten die 12-maands prijsdoelen bieden voor Capricor Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

10 ratings

Buy

Hold

Sell

Gebaseerd op 10 analisten die aandelenratings hebben gegeven aan Capricor Therapeutics Inc - Dist in de afgelopen 3 maanden.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Capricor Therapeutics Inc

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment of duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs. The company's lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase 3 clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD). It also focused on developing StealthX, an engineered exosome-based vaccine candidate, under phase 1 clinical study for a range of therapeutic applications, including targeted RNA, protein, and small molecule therapeutics to treat or prevent a variety of diseases. In addition, the company develops CAP-2003, under pre-clinical development for the treatment of trauma related injuries and conditions. It has collaboration and distribution agreement with Nippon Shinyaku Co. Ltd., collaboration agreement with National Institute of Allergy and Infectious Diseases, license agreements with the Johns Hopkins University and Cedars-Sinai Medical Center, as well as cell line license agreement with Life Technologies Corporation. The company was founded in 2005 and is headquartered in San Diego, California.